tradingkey.logo

TherapeuticsMD Inc

TXMD
2.290USD
+0.100+4.57%
收盘 02/06, 16:00美东报价延迟15分钟
26.50M总市值
87.50市盈率 TTM

TherapeuticsMD Inc

2.290
+0.100+4.57%

关于 TherapeuticsMD Inc 公司

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Inc简介

公司代码TXMD
公司名称TherapeuticsMD Inc
上市日期Jan 31, 2001
CEOWalker (Marlan D)
员工数量1
证券类型Ordinary Share
年结日Jan 31
公司地址951 Yamato Road, Suite 220
城市BOCA RATON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33431
电话15619611900
网址https://www.therapeuticsmd.com/
公司代码TXMD
上市日期Jan 31, 2001
CEOWalker (Marlan D)

TherapeuticsMD Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
448.00K
57.14%
Non-U.S
336.00K
42.86%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.43%
Tejara Capital Ltd.
3.03%
Adar1 Capital Management LLC
1.81%
其他
75.94%
持股股东
持股股东
占比
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.43%
Tejara Capital Ltd.
3.03%
Adar1 Capital Management LLC
1.81%
其他
75.94%
股东类型
持股股东
占比
Hedge Fund
18.44%
Investment Advisor
7.87%
Individual Investor
1.62%
Investment Advisor/Hedge Fund
1.39%
Research Firm
1.13%
其他
69.55%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
82
3.33M
28.78%
-21.58K
2025Q3
82
3.26M
28.17%
-348.35K
2025Q2
88
5.28M
45.63%
+1.46M
2025Q1
93
3.58M
30.94%
-393.28K
2024Q4
95
3.73M
32.32%
-2.03M
2024Q3
99
3.59M
31.15%
-463.34K
2024Q2
121
3.62M
31.37%
-2.25M
2024Q1
209
3.66M
32.13%
-802.21K
2023Q4
230
4.54M
44.12%
-1.60M
2023Q3
274
4.44M
43.31%
-158.22K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Rubric Capital Management LP
1.19M
10.3%
--
--
Sep 30, 2025
Clearline Capital LP
635.22K
5.49%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
376.83K
3.26%
-2.17K
-0.57%
Sep 30, 2025
Tejara Capital Ltd.
344.20K
2.97%
-51.00
-0.01%
Sep 30, 2025
Adar1 Capital Management LLC
209.21K
1.81%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
129.59K
1.12%
-528.00
-0.41%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
116.13K
1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
109.08K
0.94%
--
--
Sep 30, 2025
Walker (Marlan D)
73.64K
0.64%
--
--
Oct 20, 2025
Collins (Cooper C)
60.52K
0.52%
--
--
Oct 20, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
公告日期
除权除息日
类型
比率
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
KeyAI